Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity

Journal of Investigative Dermatology

Volumn 134, Issue 9, 2014, Pages 2361-2370

  Depelsenaire, Alexandra C I ^a   Meliga, Stefano C ^a   Mcneilly, Celia L ^a   Pearson, Frances E ^a   Coffey, Jacob W ^a   Haigh, Oscar L ^a   Flaim, Christopher J ^a   Frazer, Ian H ^a   Kendall, Mark A F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FLUVAX 2010; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG; NANOMATERIAL; VACCINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DELIVERY; ANTIGEN PRESENTING CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DERMATITIS; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; HYPODERMIC NEEDLE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; MICRONEEDLE; MOUSE; MULTIPHOTON MICROSCOPY; NANOMEDICINE; NANOPATCH; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN; SKIN CELL; SKIN DEFECT; SKIN SURFACE; STRESS; TISSUE INJURY; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL SURVIVAL; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; PROCEDURES; VACCINATION; CORRELATION ANALYSIS; DRUG DELIVERY DEVICE; EAR; IMMUNIZATION; VIRION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELL DEATH; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOSTRUCTURES; SKIN; VACCINATION; VACCINE POTENCY;

EID: 84906324456     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.174     Document Type: Article

References (52)

1. Auewarakul P, Kositanont U, Sornsathapornkul P, et al. (2007). Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25:659-63
2. Baskic D, Popovic S, Ristic P, et al. (2006). Analysis of cycloheximide-induced apoptosis in human leukocytes: Fluorescence microscopy using annexin V/propidium iodiDe versus acridin orange/ethidium bromide. Cell Biol Int 30:924-32
3. Belshe RB, Newman FK, Cannon J, et al. (2004). Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351:2286-94
4. Carey JB, Pearson FE, Vrdoljak A, et al. (2011). Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One 6:e22442
5. Chen X, Fernando GJP, Crichton ML, et al. (2011). Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-Term thermostabilization. J Control Release 152:349-55
6. Chen X, Kim P, Farinelli B, et al. (2010). A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS One 5:e13776
7. Chen X, Pravetoni M, Bhayana B, et al. (2012). High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine 31:159-64
8. Chen X, Prow TW, Crichton ML, et al. (2009). Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release 139:212-20
9. Chen X, Wang J, Shah D, et al. (2013). An update on the use of laser technology in skin vaccination. Expert Rev Vaccines 12:1313-23
10. Cobb JP, Hotchkiss RS, Karl IE, et al. (1996). Mechanisms of cell injury and death. Br J Anaesth 77:3-10
11. Crichton ML, Ansaldo A, Chen X, et al. (2010). The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. Biomaterials 31:4562-72
12. Darzynkiewicz Z, Bruno S, Bino GD, et al. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808
13. Ekwueme DU, Weniger BG, Chen RT. (2002). Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull World Health Organ 80:859-70
14. Fernando GJP, Chen X, Primiero CA, et al. (2012). Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release 159:215-21
15. Fernando GJP, Chen X, Prow TW, et al. (2010). Potent immunity to low doses of influenza vaccine by probabilistic guided micro-Targeted skin delivery in a mouse model. PLoS One 5:e10266
16. Franklin W, Locker J. (1981). Ethidium bromide: A nucleic acid stain for tissue section. J Histochem Cytochem 29:572-6
17. Gopee NV, Cui Y, Olson G, et al. (2005). Response of mouse skin to tattooing: Use of SKH-1 mice as a surrogate model for human tattooing. Toxicol Appl Pharmacol 209:145-58
18. Green DR, Ferguson T, Zitvogel L, et al. (2009). Immunogenic and tolerogenic cell death. Nat Rev Immunol 9:353-63
19. Gutowska-Owsiak D, Ogg GS. (2012). The epidermis as an adjuvant. J Invest Dermatol 132:940-8
20. Haq M, Smith E, John D, et al. (2009). Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed Microdevices 11:35-47
21. Hotchkiss RS, Strasser A, McDunn JE, et al. (2009). Cell Death. N Engl J Med 361:1570-83
22. Hung IFN, Levin Y, To KKW (2012a) Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination. Vaccine 30:2707-8
23. Hung IFN, Levin Y, To KKW, et al. (2012b) Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 30:6427-35
24. Jenkins D, Corrie S, Flaim C, et al. (2012). High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction. Rsc Advances 2:3490-5
25. Jiang X, Clark RA, Liu L, et al. (2012). Skin infection generates non-migratory memory CD8+T RM cells providing global skin immunity. Nature 483:227-31
26. Kenney RT, Frech SA, Muenz LR, et al. (2004). Dose Sparing with Intradermal Injection of Influenza Vaccine. N Engl J Med 351:2295-301
27. Kim Y-C, Park J-H, Prausnitz MR (2012a) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547-68
28. Kim YC, Jarrahian C, Zehrung D, et al. (2012b) Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351:77-112
29. Kinsey BM, Marcelli M, Song L, et al. (2004). Enhancement of both cellular and humoral responses to genetic immunization by co-Administration of an antigen-expressing plasmid and a plasmid encoding the pro-Apoptotic protein Bax. J Gene Med 6:445-54
30. Kis EE, Winter G, Myschik J. (2012). Devices for intradermal vaccination. Vaccine 30:523-38
31. Kojima Y, Jounai N, Takeshita F, et al. (2007). The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection. Vaccine 25:438-45
32. Kono H, Rock KL. (2008). How dying cells alert the immune system to danger. Nat Rev Immunol 8:279-89
33. Koutsonanos DG, Compans RW, Skountzou I. (2013). Targeting the skin for microneedle delivery of influenza vaccine. Adv Exp Med Biol 785:121-32
34. Kupper TS. (2012). Old and new: Recent innovations in vaccine biology and skin T cells. J Invest Dermatol 132:829-34
35. Liu L, Zhong Q, Tian T, et al. (2010). Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16:224-7
36. Marichal T, Ohata K, Bedoret D, et al. (2011). DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17:996-1002
37. Matzinger P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045
38. Meliga SC, Flaim C, Veidt M, et al. (2013). The mechanical stress caused by microprojection arrays penetrating the skin for vaccine delivery. J Multidiscipl Eng 10:173-84
39. Milewski M, Brogden NK, Stinchcomb AL. (2010). Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv 7:617-29
40. Ng H-I, Fernando GJP, Kendall MAF. (2012). Induction of potent CD8+ T-cell responses through the delivery of subunit protein vaccines to skin antigenpresenting cells using densely packed microprojection arrays. J Control Release 162:477-84
41. Pokorná D, Rubio I, Müller M. (2008). DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther 6:4
42. Prausnitz MR, Mikszta JA, Cormier M, et al. (2009). Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369-93
43. Quan F-S, Kim Y-C, Compans RW, et al. (2010). Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release 147:326-32
44. Raju PA, McSloy N, Truong NK, et al. (2006). Assessment of epidermal cell viability by near infrared multi-photon microscopy following ballistic delivery of gold micro-particles. Vaccine 24:4644-7
45. Raphael AP, Meliga SC, Chen X, et al. (2013). Depth-resolved characterization of diffusion properties within and across minimally-perturbed skin layers. J Control Release 166:87-94
46. Rock KL, Kono H. (2008). The inflammatory response to cell death. Annu Rev Pathol 3:99-126
47. Rovere-Querini P, Capobianco A, Scaffidi P, et al. (2004). HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5:825-30
48. Skala MC, Squirrell JM, Vrotsos KM, et al. (2005). Multiphoton microscopy of endogenous fluorescence differentiates normal, precancerous, and cancerous squamous epithelial tissues. Cancer Res 65:1180-6
49. Van Damme P, Oosterhuis-Kafeja F, Van Der Wielen M, et al. (2009). Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454-9
50. Yang Y-W, Shen S-S. (2007). Enhanced antigen delivery via cell death induced by the vaccine adjuvants. Vaccine 25:7763-72
51. Yang Y-W, Wu C-A, Morrow WJW (2004a) The apoptotic and necrotic effects of tomatine adjuvant. Vaccine 22:2316-27
52. Yang Y-W, Wu C-A, Morrow WJW (2004b) Cell death induced by vaccine adjuvants containing surfactants. Vaccine 22:1524-36.